Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn's disease
Conclusions
Autologous HSCT for patients with refractory CD is feasible, but extraordinary supportive measures need to be implemented. We suggest that this procedure should only be performed in highly experienced centres.
Source: Gut - Category: Gastroenterology Authors: Jauregui-Amezaga, A., Rovira, M., Marin, P., Salas, A., Pino-Donnay, S., Feu, F., Elizalde, J. I., Fernandez-Aviles, F., Martinez, C., Gutierrez, G., Rosinol, L., Carreras, E., Urbano, A., Lozano, M., Cid, J., Suarez-Lledo, M., Mensa, J., Rimola, J., Rodr Tags: Crohn's disease Inflammatory bowel disease Source Type: research
More News: Crohn's Disease | Cytomegalovirus | Gastroenterology | Inflammatory Bowel Disease | Men | Stem Cell Therapy | Stem Cells | Study | Toxicology | Transplants